Navigation Links
Hormone Therapy Increases Odds of Ovarian Cancer
Date:7/14/2009

But risk remains low and decreases two years after stopping, study finds,,

TUESDAY, July 14 (HealthDay News) -- Women who take hormone replacement therapy or have taken it in the recent past have a higher risk of developing ovarian cancer, suggests new research.

In a large Danish study, compared to women who never took hormone replacement therapy, current users had a 38 percent increased risk of ovarian cancer and a 44 percent increased risk of epithelial ovarian cancer, which is cancer that begins on the outer lining of the ovary. The results were reported in the July 15 issue of the Journal of the American Medical Association.

The absolute risk for any one woman is still quite small, however. The researchers calculated that for every 8,300 women, hormone therapy would result in one extra case of ovarian cancer a year.

"Our study underlines previous evidence that postmenopausal hormones increase the risk of ovarian cancer," said the study's lead author, Lina Steinrud Morch of the gynecological clinic at the Rigshospitalet of Copenhagen University in Denmark. "The risk among women taking hormones was increased regardless of the duration of use, the formulation, the estrogen dose, regimen, progestin type or route of administration," she added.

And, although the absolute risk of ovarian cancer remained low, Morch noted, "ovarian cancer is the most lethal of gynecologic cancers. The five-year survival rates are 40 percent. Only a few risk factors for ovarian cancer are modifiable."

The study included all Danish women (909,946) between the ages of 50 to 79 at the start of the study. During eight years of follow-up, the researchers found 3,068 cases of ovarian cancer. Of these, 2,681 were epithelial ovarian cancers.

As soon as women stopped taking hormones, the risk of ovarian cancer decreased. Women who had just stopped taking hormones compared to those who were off for les
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapy
2. JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumor
3. Growth Hormone May Build Muscle in Older Men
4. Hormones May Affect Neurological Disease Risk
5. Hormone Could Improve Diabetes Treatment
6. Appetite-stimulating hormone is first potential medical treatment for frailty in older women
7. MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™
8. Longer Hormone Treatment May Improve Prostate Cancer Outlook
9. Hormone therapy may confer more aggressive properties to prostate tumors
10. Pausing Hormone Therapy Doesnt Cut Mammogram Recalls
11. Fighting "Brain Fog": How the Right Hormones Can Improve Mental Sharpness for Women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Therapy Increases Odds of Ovarian Cancer
(Date:3/2/2015)... Surgeons at the Forbes Hospital Trauma ... are exploring an innovative use of Google Glass technology, ... (VIZR), to assist in the care of critically injured ... wearable technology with an optical head-mounted display that provides ... the Internet via natural language voice commands. , Forbes’ ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Ticket Down ... at the Hollywood Bowl . This popular site has ... appreciation promo code JIMMY-BUFFETT-2015 for added savings. , Parrotheads ... favorite performer will be headlining at the Hollywood Bowl ... will be on Thursday, October 22nd and it will ...
(Date:3/2/2015)... 02, 2015 Doctors in Novara, Italy ... better predictor of outcomes for people with mesothelioma than ... of the new study on the Surviving Mesothelioma ... University of Eastern Piedmont followed the cases of 172 ... for excess lung fluid. , “Persistent lung expansion ...
(Date:3/2/2015)... 2015 Burns Engineering's Lab-to-Lab Calibration ... Secondary Standard Platinum Resistance Thermometers (SSPRTs) and industrial ... or less . . . guaranteed. ... (Lab Code 200706-0), ISO 9001 and 17025 Certified ... is -196°C to 500°C, both ITS-90 and Callendar-van ...
(Date:3/2/2015)... March 02, 2015 The minimally ... at a CAGR of 6.1% to reach $14,133.0 ... , Factors such as advantages of minimally ... costs owing to minimally invasive surgeries and increasing ... are driving the global minimally invasive surgical instruments ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2
... epilepsy drug would help alcoholics quit drinking. Texas Health ... the alcoholics who took Topiramate, an anti-seizure drug quit ... placebo treatment, those given Topiramate were six times more ... the drug acts against the chemicals that provide pleasure ...
... fatter not because they are eating more, but because ... diet, weight, and physical activity of teens they found ... 1%, while physical activity dropped 13%. Even though experts ... agree teens have not been overeating. The study indicated ...
... capable of sniffing out distinctive odor of lung cancer patients. ... be accurate. The electronic nose is a 12 cm cube ... asked to exhale into a sterilized bag which is connected ... cube and hence into the sensors. The sensors identify the ...
... main cause of deadly brain-wasting diseases might be just ... - Cannibalism. Abnormal proteins called the prions resultantly ... and bovine spongiform encephalopathy, or mad cow disease in ... to be clumped together. CJD is usually found in ...
... Alzheimer’s disease continues to fuel research, as the incidence ... drug has been developed to slow the course of ... which is one of the brain’s messenger and this ... memory are the fields, which are enabled by the ...
... regular mammograms could reduce their risk of dying from ... and medical community as a benefit to women. However ... the 70's and 80's concluded X-rays can cut deaths ... it was impossible to tell if routine mammograms saved ...
Cached Medicine News:Health News:Brain diseases an outcome of cannibalism, 2
(Date:3/2/2015)... Ill. , March 2, 2015  Landauer, Inc. ... personal and environmental radiation measurement and monitoring, outsourced medical ... announced it will release financial results for the fiscal ... March 9, 2015. The Company will ... March 10, 2015 at 9:00 a.m. Central Time (10:00 ...
(Date:3/2/2015)... , March 2, 2015  Actavis plc ... it has closed its concurrent offerings of 14,513,889 ... 5.500% Mandatory Convertible Preferred Shares, Series A, at ... a separate registered public offering.  The amounts sold ... Preferred Shares issued pursuant to the exercise in ...
(Date:3/2/2015)... 2015  BC Technical, the nation,s leading non-OEM ... Systems, a Nuclear Imaging service company providing systems, ... their ongoing vision to provide the best, and ... Technical continues to expand their reach and expertise. ... valuable resources and knowledge in addition to strengthening ...
Breaking Medicine Technology:Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 2Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 3Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 4Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 5Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 6Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 7Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 8BC Technical Acquires Eclipse Systems 2
... WARSAW, Ind., Oct. 27, 2011 Zimmer Holdings, Inc. (NYSE ... ended September 30, 2011.  The Company reported third quarter net ... reported and 2.4% constant currency over the third quarter of ... reported and $1.04 adjusted, an increase of 8.3% adjusted over ...
... Sigma-Aldrich Corporation (NASDAQ: SIAL ) today ... SAFC® ( www.safcglobal.com ), is introducing a novel CHOZN® ... cell line. Designed for use in the production of ... first commercially available glutamine synthetase (GS) knockout CHO cell ...
Cached Medicine Technology:Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 2Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 3Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 4Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 5Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 6Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 7Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 8Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 9Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 10Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 11Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 12SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 2SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 3SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 4
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Medicine Products: